Skip to main content
editorial
. 2019 Jun 8;70(8):1691–1694. doi: 10.1093/cid/ciz488

Figure 2.

Figure 2.

Survival in CrAg-positive persons by plasma CrAg titer. Among asymptomatic persons in whom CSF CrAg positivity was excluded, similar outcomes occurred among those with a CrAg titer ≤1:320 regardless of symptoms (P = .68). CNS symptoms most dramatically decreased survival among those with plasma CrAg titers of 1:160 to 1:320, frequently associated with a positive CSF CrAg. Poor survival occurred among persons with plasma CrAG titers >1:640, regardless of symptoms. Neither symptoms nor CSF CrAg status predicted CNS dissemination in this group with high plasma titers. Abbreviation: CrAg, cryptococcal antigen.